CME Group (NASDAQ:CME) – Analysts at Jefferies Group upped their FY2018 earnings estimates for shares of CME Group in a note issued to investors on Tuesday, April 3rd, Zacks Investment Research reports. Jefferies Group analyst D. Fannon now expects that the financial services provider will earn $7.03 per share for the year, up from their previous estimate of $6.57. Jefferies Group also issued estimates for CME Group’s FY2019 earnings at $7.06 EPS.
CME Group (NASDAQ:CME) last announced its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.10 by $0.02. CME Group had a return on equity of 7.68% and a net margin of 111.49%. The firm had revenue of $900.00 million for the quarter, compared to the consensus estimate of $886.85 million. During the same period in the previous year, the business earned $1.14 EPS. The firm’s revenue for the quarter was down 1.4% on a year-over-year basis.
CME has been the topic of several other reports. Sanford C. Bernstein began coverage on CME Group in a research note on Monday, April 9th. They set an “outperform” rating and a $190.00 target price on the stock. Zacks Investment Research downgraded CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 6th. Berenberg Bank began coverage on CME Group in a research note on Thursday, January 25th. They set a “hold” rating and a $170.00 target price on the stock. ValuEngine upgraded CME Group from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Finally, Goldman Sachs raised CME Group from a “neutral” rating to a “buy” rating and set a $180.00 price target for the company in a research report on Wednesday, February 7th. Three equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. CME Group presently has an average rating of “Buy” and an average price target of $165.57.
Shares of CME stock opened at $164.47 on Thursday. CME Group has a 1-year low of $114.82 and a 1-year high of $171.71. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.10. The firm has a market cap of $56,081.83, a P/E ratio of 34.48, a price-to-earnings-growth ratio of 2.29 and a beta of 0.56.
Hedge funds have recently modified their holdings of the company. ARK Investment Management LLC acquired a new position in shares of CME Group in the 4th quarter valued at about $120,000. Valeo Financial Advisors LLC acquired a new position in CME Group in the 3rd quarter worth about $124,000. AlphaOne Investment Services LLC acquired a new position in CME Group in the 4th quarter worth about $146,000. Mosaic Family Wealth LLC acquired a new position in CME Group in the 4th quarter worth about $146,000. Finally, Truewealth LLC acquired a new position in CME Group in the 4th quarter worth about $157,000. 83.41% of the stock is owned by institutional investors and hedge funds.
In other news, insider Hilda Harris Piell sold 3,299 shares of the business’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $163.52, for a total value of $539,452.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Derek Sammann sold 2,400 shares of the business’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $161.66, for a total value of $387,984.00. Following the completion of the transaction, the insider now directly owns 40,153 shares of the company’s stock, valued at approximately $6,491,133.98. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 35,699 shares of company stock valued at $5,532,362. 0.57% of the stock is currently owned by insiders.
The company also recently declared a quarterly dividend, which was paid on Monday, March 26th. Shareholders of record on Friday, March 9th were given a dividend of $0.70 per share. The ex-dividend date of this dividend was Thursday, March 8th. This represents a $2.80 dividend on an annualized basis and a yield of 1.70%. This is a boost from CME Group’s previous quarterly dividend of $0.66. CME Group’s payout ratio is currently 58.70%.
TRADEMARK VIOLATION NOTICE: “Jefferies Group Comments on CME Group’s FY2018 Earnings (NASDAQ:CME)” was first reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at https://www.thelincolnianonline.com/2018/04/20/fy2018-earnings-forecast-for-cme-group-inc-cme-issued-by-jefferies-group.html.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.